Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
Furler J, O'Neal D, Speight J, Blackberry I, Manski-Nankervis JA, Thuraisingam S, de La Rue K, Ginnivan L, Doyle R, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins A, Lake AJ, Januszewski AS, Catchpool M, Liew D, Clarke P, Best J.
Furler J, et al. Among authors: audehm r.
Lancet Diabetes Endocrinol. 2020 Jan;8(1):17-26. doi: 10.1016/S2213-8587(19)30385-7.
Lancet Diabetes Endocrinol. 2020.
PMID: 31862147
Clinical Trial.